Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, March 4, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Medtech
Follett Products, LLC and PHC Corporation of North America Partner to Supply Ultra-Low Temperature Freezers to Healthcare Facilities
Life Sciences Times
-
February 4, 2021
0
Biotech
Catamaran Bio Appoints Alvin Shih as President and CEO
Life Sciences Times
-
February 4, 2021
0
People on the Move
GenapSys Names Jason Myers CEO
Life Sciences Times
-
February 4, 2021
0
Biotech
PerkinElmer’s Horizon Discovery Cell Line Supports Trinomab Biotech’s Development of the Tetanus Toxin mAb Drug for Clinical Trials
Life Sciences Times
-
February 4, 2021
0
Medtech
Eurosets Announces the Full Commercial Release of Its Novel ExtraCorporeal Life Support System, ECMOLife
Life Sciences Times
-
February 3, 2021
0
Venture Capital
Flywheel Secures $15M in Series B Funding
Life Sciences Times
-
February 3, 2021
0
Life Sciences
TMRW Launches World’s First Automated Platform to Safeguard Millions of Frozen Eggs and Embryos
Life Sciences Times
-
February 3, 2021
0
Life Sciences
LifeNet Health LifeSciences isolates primary human lung cells to aid and accelerate efforts in COVID-19 drug development
Life Sciences Times
-
February 3, 2021
0
Biotech
Novel injection to treat skin cancer
Life Sciences Times
-
February 3, 2021
0
Public Health
Too much sugar intake in childhood can alter microbiome for life
Life Sciences Times
-
February 3, 2021
0
1
...
782
783
784
...
805
Page 783 of 805
TOP AUTHORS
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Most Read
Mobile Heartbeat Expands Banyan Platform Integration With Microsoft Teams to Improve Enterprise Communication
March 3, 2026
Syntis Bio Doses First Patient in Phase 1/1b Trial of Oral Obesity Drug SYNT-101, Expands Leadership Team
March 3, 2026
Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases
March 3, 2026
Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion
March 3, 2026